Colgate-Palmolive (NYSE:CL) Shares Bought by Allen Mooney & Barnes Investment Advisors LLC

Allen Mooney & Barnes Investment Advisors LLC increased its stake in Colgate-Palmolive (NYSE:CLFree Report) by 5.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,863 shares of the company’s stock after acquiring an additional 198 shares during the period. Allen Mooney & Barnes Investment Advisors LLC’s holdings in Colgate-Palmolive were worth $308,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Secure Asset Management LLC purchased a new stake in Colgate-Palmolive during the fourth quarter valued at about $214,000. Mayflower Financial Advisors LLC grew its holdings in shares of Colgate-Palmolive by 19.7% during the 4th quarter. Mayflower Financial Advisors LLC now owns 9,136 shares of the company’s stock worth $728,000 after purchasing an additional 1,503 shares during the period. Alliance Wealth Management Group acquired a new stake in Colgate-Palmolive during the 4th quarter worth approximately $273,000. AMI Asset Management Corp purchased a new position in Colgate-Palmolive in the fourth quarter valued at approximately $32,246,000. Finally, Realta Investment Advisors lifted its position in Colgate-Palmolive by 11.4% during the fourth quarter. Realta Investment Advisors now owns 7,965 shares of the company’s stock valued at $635,000 after buying an additional 812 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $90.05 on Monday. Colgate-Palmolive has a one year low of $67.62 and a one year high of $90.37. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.71 and a current ratio of 1.11. The stock has a market capitalization of $74.02 billion, a price-to-earnings ratio of 32.39, a PEG ratio of 3.43 and a beta of 0.42. The company’s 50-day simple moving average is $85.90 and its 200-day simple moving average is $79.29.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its quarterly earnings data on Friday, January 26th. The company reported $0.87 earnings per share for the quarter, beating analysts’ consensus estimates of $0.85 by $0.02. The business had revenue of $4.95 billion during the quarter, compared to the consensus estimate of $4.89 billion. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The company’s revenue for the quarter was up 6.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.77 EPS. Equities analysts anticipate that Colgate-Palmolive will post 3.49 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be issued a dividend of $0.50 per share. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.00 annualized dividend and a dividend yield of 2.22%. Colgate-Palmolive’s payout ratio is 69.06%.

Analyst Upgrades and Downgrades

CL has been the topic of a number of research reports. JPMorgan Chase & Co. raised their target price on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the company an “overweight” rating in a research note on Thursday, January 18th. Raymond James upgraded Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 target price for the company in a research note on Monday, January 29th. Morgan Stanley boosted their price target on Colgate-Palmolive from $85.00 to $93.00 and gave the stock an “overweight” rating in a research report on Monday, January 29th. UBS Group increased their price objective on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Monday, January 29th. Finally, The Goldman Sachs Group started coverage on shares of Colgate-Palmolive in a research report on Friday, March 1st. They set a “buy” rating and a $93.00 target price on the stock. Three equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $87.31.

Check Out Our Latest Analysis on CL

Insider Transactions at Colgate-Palmolive

In related news, insider Jennifer Daniels sold 3,538 shares of Colgate-Palmolive stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $84.67, for a total value of $299,562.46. Following the sale, the insider now directly owns 59,698 shares in the company, valued at approximately $5,054,629.66. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, EVP Gregory Malcolm sold 8,930 shares of Colgate-Palmolive stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $85.35, for a total transaction of $762,175.50. Following the sale, the executive vice president now directly owns 8,043 shares in the company, valued at $686,470.05. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Jennifer Daniels sold 3,538 shares of the stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $84.67, for a total transaction of $299,562.46. Following the completion of the transaction, the insider now owns 59,698 shares of the company’s stock, valued at approximately $5,054,629.66. The disclosure for this sale can be found here. Over the last quarter, insiders sold 232,371 shares of company stock worth $19,505,099. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.